Gen9 is building on advances in synthetic biology to power a scalable fabrication capability that will significantly increase the world's capacity to compile DNA content.
Our next-generation DNA synthesis technology allows for the high-throughput, automated production of DNA constructs at lower cost and higher accuracy than previous methods on the market.
Gen9 aims to ensure the constructive application of synthetic biology in industries ranging from enzyme and chemical production to pharmaceuticals and biofuels.
What's New at Gen9
Gen9 sponsors Mammalian Synthetic Biology Workshop - May 11-12 at MIT